Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia

Table 2 Retrospective and prospective studies used for this investigation

				Patient characteristics					Organ systems affected by associated NPL
Au-thor	Year	Date of diag-nosis	N	Age average (median)		Sex m/f		Nu-mber (rate) of pati-ents with ass. NPL	GI-tract	Liver/ gall bla-dder/ pan-creas	Uro geni-tal tract	Fem-ale geni-tal tract	Bre-ast	Blo-od/ lymp-hatic sys-tem	Head and neck	Lung	Skin/ mela noma	Soft	Other
				Total pop-ula-tion	Pat. with ass. NPL	Total pop-ula-tion	Pat. with ass. NPL
Ad-im et al[137]	2011	1997-2009	78		62		9/4	13 (17%)	9	2	1		1
Aga-imy et al[14]	2005	1997-2004	97	65	72	42/55	6/12	18 (17%)	6	3	2	3	2	2		2
Agh-das-si et al[138]	2018	1993-2011	104	67		54/50		44 (42%)	16	4	8		7	2				1
Am-aad-our et al[139]	2013	1998-2006	43	62	65	15/28	1/5	6 (14%)	5				1
Fer-nan-dez et al[140]	2018	1999-2016	104		64	62/42	22/10	32 (31%)	9	4	7		3	3	2	2	1	1
Ferr-eira et al[141]	2010	1998-2006	43	62	61	15/28	1/5	6 (14%)	5				1
Giu-liani et al[142]	2012	2002-2010	24	66	69	12/12	5/3	8 (33%)	6		1		1
Gon-alves et al[143]	2010	1998-2008	101		68		5/9	14 (14%)	8		2	2	1						1
Hec-htm-ann et al[144]	2015	2009-2013	260		65	142/118	30/20	50 (19%)	2		21	1	8	8	7	1	3	3	6
Kra-mer et al[17]	2015	2006-2011	836	68	69	423/413	148/119	422 (51%)	118	20	60	22	26	23	6	8	23	2	9
Lai et al[145]	2016	1995-2015	749		68		77/59	136 (18%)	64	27	12	10	7	1	9	13	4	3	10
Lis-zka et al[146]	2007	1989-2006	82		64	38/44	12/10	22 (27%)	17	5				1
Ma-yr et al[15]	2019	1998-2017	188		69			70 (37%)	23	1	17	9	5	5		2	5		3
Mur-phy et al[12]	2015	2001-2011	6112			3252/2860	727/481	1047 (17%)	208	34	432		144	80	54	99	52	48	72
Pan-dur-eng-an et al[147]	2010	1995-2007	783	57		444/339	91/62	153 (20%)	40	8	48	14	15	12	1	10	9	9	20
Ponti et al[148]	2010	1988-2007	141	66	67	77/64	20/26	46 (33%)	18	1	7	2	6	1		2	1	2	3
Ric-hter et al[149]	2008	1993-2005	54	65		28/26		13 (20%)	7		3		1	1					1
Rod-riq-uenz et al[150]	2016	2002-2014	128	65	68	59/69	19/27	46 (34%)	24	5	3	4	2	1	1	3		3	1
Rub-io-Cas-ade-vall et al[151]	2015	1996-2006	132	65		67/53		30 (23%)	8	2	3	1	3			3
Sevi-nc et al[152]	2011	2002-2009	200		67		20/12	32 (16%)	16		5	1	2	1	2			1	4
Smi-th et al[13]	2016	2001-2009	1705	63	69	885/820	95/86	181 (11%)
Vas-sos et al[153]	2014	2000-2009	86	66	70	50/36	27/10	37 (43%)	19	7	5			4	3		3	1
			12050	63	68	1.1 : 1	1.4 : 1	2426 (20,1%)	751 (32%)		706 (30%)		236 (10%)	145 (6%)	85 (4%)	145 (6%)	101 (4%)	74 (3%)	130 (5%)